Specifically, elevated IL-6 and IL-10 levels observed in COVID-19, can inhibit NK cytotoxicity, mediated by Granzyme-B production, Fas/FasL (Fas ligand) interaction and CD16 binding with the Fc (constant fraction) of antibodies. The gene discussed is IL10; the disease is COVID-19.